A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis

INTRODUCTION: The standard therapy for American cutaneous leishmaniasis (ACL) is intravenous meglumine antimoniate (IV-MA). However, treatment interruptions due to adverse events (AEs) and non-adherence are frequent. Consequently, intralesional MA (IL-MA) was proposed. OBJECTIVE: This study examined...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Parasitol Drugs Drug Resist
Autors principals: Rodrigues, Bruna Côrtes, Ferreira, Marina Freitas, Barroso, Daniel Holanda, Motta, Jorgeth Oliveira Carneiro da, Paula, Carmen Déa Ribeiro de, Porto, Cláudia, Martins, Sofia Sales, Gomes, Ciro Martins, Sampaio, Raimunda Nonata Ribeiro
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7723996/
https://ncbi.nlm.nih.gov/pubmed/33285343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2020.11.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars